Isolated microcytic anemia disclosing a unicentric Castleman disease: The interleukin-6/hepcidin pathway?

European Journal of Internal Medicine

Volumn 19, Issue 5, 2008, Pages 367-369

  Vinzio, Stéphane ^a   Ciarloni, Laetitia ^a   Schlienger, Jean Louis ^a   Rohr, Serge ^a   Méchine, Agnès ^a   Goichot, Bernard ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Anemia; Castleman disease; Hepcidin; Interleukin 6; Iron; Review

Indexed keywords

HEPCIDIN; INTERLEUKIN 6;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; HISTOPATHOLOGY; HUMAN; IRON BLOOD LEVEL; IRON METABOLISM; LABORATORY TEST; MALE; MICROCYTIC ANEMIA; TRANSFERRIN BLOOD LEVEL;

ADULT; ANEMIA; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIMICROBIAL CATIONIC PEPTIDES; ERYTHROCYTE INDICES; GIANT LYMPH NODE HYPERPLASIA; HUMANS; INTERLEUKIN-6; IRON; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 44649116517     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.09.006     Document Type: Article

References (6)

1. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 129 (2005) 3-17
2. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113 (2004) 1271-1276
3. Torres Valdivieso M.J., Lopez Perez J., Melero Moreno C., Vivanco Martinez J.L., Peralta Ibanez M.L., Nieto Del Rincon N., et al. Microcytic anemia resistant to the oral administration of iron as a form of presentation of the Castleman disease. An Esp Pediatr 51 (1999) 74-76
4. Veldhuis G.J., van der Leest A.H., de Wolf J.T., de Vries E.G., and Vellenga E. A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects. Ann Hematol 73 (1996) 47-50
5. Nishimoto N., Sasai M., Shima Y., Nakagawa M., Matsumoto T., Shirai T., et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95 (2000) 56-61
6. Hattori K., Irie S., Isobe Y., Wakiya M., Matsumoto T., Suda K., et al. Multicentric Castleman's disease associated with renal amyloidosis and pure red cell aplasia. Ann Hematol 77 (1998) 179-181